Dermoid Cyst: Diagnostic Workup and Management
For ovarian dermoid cysts <10 cm, ultrasound is the primary diagnostic modality, and management depends on menopausal status: premenopausal patients require optional 8-12 week follow-up with annual surveillance if not excised, while postmenopausal patients need annual ultrasound follow-up with heightened vigilance for malignant transformation. 1
Diagnostic Workup
Ultrasound Imaging
- Transvaginal ultrasound combined with transabdominal ultrasound is the first-line imaging modality for suspected ovarian dermoid cysts 1
- Characteristic ultrasound features include:
Risk Stratification
- Dermoid cysts <10 cm are classified as O-RADS 2 (almost certainly benign, <1% malignancy risk) when they demonstrate classic benign features 1
- Dermoid cysts ≥10 cm are classified as O-RADS 3 (low risk, 1-<10% malignancy risk) 1
Advanced Imaging Indications
- MRI or ultrasound specialist consultation is indicated when:
Management Algorithm
Premenopausal Patients
For dermoid cysts <10 cm:
- Optional initial follow-up at 8-12 weeks based on diagnostic confidence 1
- Annual ultrasound surveillance is recommended if not surgically excised 1
- Management typically coordinated by gynecologist 1
For dermoid cysts ≥10 cm:
- Management by general gynecologist 1
- Consultation with ultrasound specialist or MRI recommended to exclude suspicious features 1
- No gynecologic oncology consultation needed (>90% benign) 1
Postmenopausal Patients
For dermoid cysts <10 cm:
- Annual ultrasound follow-up when not surgically excised 1
- Higher vigilance required due to increased risk of malignant transformation 1
- Consider direct MRI referral if morphologic changes develop 1
For dermoid cysts ≥10 cm:
- Management by general gynecologist with ultrasound specialist consultation or MRI 1
- Heightened concern for malignancy compared to premenopausal patients 1
Critical Management Considerations
Surgical Approach
- Laparoscopic excision is preferred for most cases, associated with lower perioperative complications 2
- Ovarian preservation should be prioritized, particularly in adolescents and reproductive-age women 3, 2
- Cyst spillage occurs more frequently with minimally invasive surgery but chemical peritonitis is rare (0.25% in large series) 2
Torsion Risk
- Overall torsion rate is 5.6%, with risk increasing with cyst size 2
- Fertility-sparing treatment should be attempted when torsion occurs 3
Malignant Transformation
- Malignant transformation rate is 1.1% overall 2
- Risk is higher in postmenopausal patients, particularly for clear cell and endometrioid carcinomas 1
- Sonographically diagnosed dermoids can be safely followed with yearly ultrasound, as risk of missing malignant degeneration is quite low 1
Bilateral Disease
- Bilateral dermoid cysts occur in approximately 10.7% of cases 2
- Careful examination of contralateral ovary is essential 2
Common Pitfalls to Avoid
- Do not routinely obtain tumor markers (CA-125) for O-RADS 2 or 3 lesions, as the O-RADS committee specifically recommends against routine use 1
- **Do not refer to gynecologic oncology for typical dermoid cysts <10 cm**, as >90% are benign 1
- Do not assume hemorrhagic cysts in postmenopausal patients are physiologic—these warrant further evaluation as they should not occur in this population 1
- Ensure complete excision to prevent recurrence, as incomplete excision is associated with recurrence risk 4